Susquehanna International Group’s Bionano Genomics, Inc. Warrant BNGOW Stock Holding History

Susquehanna International Group’s Portfolio BNGOW Stock Details BNGOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-103,690	Closed	-$23K	–	11914
2020 Q3	$23K	Buy	103,690 +504	+0.5%	+$102	﹤0.01%	10370
2020 Q2	$13K	Buy	103,186 +74,344	+258%	+$8.07K	﹤0.01%	9963
2020 Q1	$3K	Sell	28,842 -59,404	-67%	-$14.2K	﹤0.01%	10124
2019 Q4	$28K	Buy	+88,246	New	+$14.9K	﹤0.01%	9450

Other funds holding BNGOW

MIM

Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's BNGOW Position: Q4 2020 in Review

Susquehanna International Group sold out of Bionano Genomics, Inc. Warrant (BNGOW) in Q4 2020, closing a stake of 103,690 shares — an estimated $23K sold.

Susquehanna International Group first reported a position in BNGOW in Q4 2019 and held it in 4 quarters. The position peaked at $28K in Q4 2019. 4 funds tracked by Wall St. Rank hold BNGOW as of Q4 2020.

Susquehanna International Group reported no remaining Bionano Genomics, Inc. Warrant position as of Q4 2020 after selling out during the quarter.
Susquehanna International Group sold 103,690 Bionano Genomics, Inc. Warrant shares in Q4 2020, an estimated $23K.
Susquehanna International Group first reported a position in Bionano Genomics, Inc. Warrant in Q4 2019 and held it in 4 quarters.
Susquehanna International Group's Bionano Genomics, Inc. Warrant position peaked at $28K in Q4 2019.
4 funds tracked by Wall St. Rank held Bionano Genomics, Inc. Warrant as of Q4 2020.

Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.